Garratty G. The role of compatibility tests. Transfusion 1982;22:169–72.GarrattyG.The role of compatibility tests.Transfusion1982;22:169–72.10.1046/j.1537-2995.1982.22282177132.x6803410Search in Google Scholar
Office of Biologics Research and Review, National Center for Drugs and Biologics, United States. Equivalent methods for compatibility testing: memorandum to blood establishments. Washington, DC: Food and Drug Administration, 1984.Office of Biologics Research and Review, National Center for Drugs and Biologics, United States.Equivalent methods for compatibility testing: memorandum to blood establishments.Washington, DC:Food and Drug Administration,1984.Search in Google Scholar
AABB. Standards for blood banks and transfusion services, 31st ed. Bethesda, MD: AABB, 2018.AABB.Standards for blood banks and transfusion services,31st ed.Bethesda, MD:AABB,2018.Search in Google Scholar
Chow EY. The impact of the type and screen test policy on hospital transfusion practice. Hong Kong Med J 1999;5:275–9.ChowEY.The impact of the type and screen test policy on hospital transfusion practice.Hong Kong Med J1999;5:275–9.Search in Google Scholar
Cordle DG, Strauss RG, Snyder EL, Floss AM. Safety and cost-containment data that advocate abbreviated pretransfusion testing. Am J Clin Pathol 1990;94:428–31.CordleDGStraussRGSnyderELFlossAM.Safety and cost-containment data that advocate abbreviated pretransfusion testing.Am J Clin Pathol1990;94:428–31.10.1093/ajcp/94.4.4282220670Search in Google Scholar
Heddle NM, O’Hoski P, Singer J, McBride JA, Ali MA, Kelton JG. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol 1992;81:579–84.HeddleNMO’HoskiPSingerJMcBrideJAAliMAKeltonJG.A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.Br J Haematol1992;81:579–84.10.1111/j.1365-2141.1992.tb02995.x1390245Search in Google Scholar
Fung MK, Eder AF, Spitalnik SL, Westhoff CM, Eds. Technical manual. 19th ed. Bethesda, MD: AABB Press, 2017.FungMKEderAFSpitalnikSLWesthoffCM, Eds.Technical manual.19th ed.Bethesda, MD:AABB Press,2017.Search in Google Scholar
Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion. Transfusion 1978;18:137–41.ObermanHABarnesBAFriedmanBA.The risk of abbreviating the major crossmatch in urgent or massive transfusion.Transfusion1978;18:137–41.10.1046/j.1537-2995.1978.18278160574.x417431Search in Google Scholar
Marosszeky S, McDonald S, Sutherland J, et al. Suitability of preadmission blood samples for pretransfusion testing in elective surgery. Transfusion 1997;37:910–2.MarosszekySMcDonaldSSutherlandJ,Suitability of preadmission blood samples for pretransfusion testing in elective surgery.Transfusion1997;37:910–2.10.1046/j.1537-2995.1997.37997454016.x9308636Search in Google Scholar
Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA. Multiple red cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995;119:42–5.HoeltgeGADomenRERybickiLASchafferPA.Multiple red cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993.Arch Pathol Lab Med1995;119:42–5.Search in Google Scholar
Chow EY. The impact of the type and screen test policy on hospital transfusion practice. Hong Kong Med J 1999;5:275–9.ChowEY.The impact of the type and screen test policy on hospital transfusion practice.Hong Kong Med J1999;5:275–9.Search in Google Scholar
Zeerleder S. Autoimmune haemolytic anaemia: a practical guide to cope with a diagnostic and therapeutic challenge. Neth J Med 2011;69:177–84.ZeerlederS.Autoimmune haemolytic anaemia: a practical guide to cope with a diagnostic and therapeutic challenge.Neth J Med2011;69:177–84.Search in Google Scholar
Uthemann H, Poschmann A. Solid-phase antiglobulin test for screening and identification of red cell antibodies. Transfusion 1990;30:114–6.UthemannHPoschmannA.Solid-phase antiglobulin test for screening and identification of red cell antibodies.Transfusion1990;30:114–6.10.1046/j.1537-2995.1990.30290162895.x2305439Search in Google Scholar
Agrawal A. Type and screen policy: is there any compromise on blood safety? Transfus Apher Sci 2014;50:271–3.AgrawalA.Type and screen policy: is there any compromise on blood safety?Transfus Apher Sci2014;50:271–3.10.1016/j.transci.2014.01.00324472664Search in Google Scholar
Pathak S, Chandrashekhar M, Wankhede GR. Type and screen policy in the blood bank: is AHG cross-match still required? A study at a multispecialty corporate hospital in India. Asian J Transfus Sci 2011;5:153–6.PathakSChandrashekharMWankhedeGR.Type and screen policy in the blood bank: is AHG cross-match still required? A study at a multispecialty corporate hospital in India.Asian J Transfus Sci2011;5:153–6.10.4103/0973-6247.83242315924621897595Search in Google Scholar
Chaudhary R, Agarwal N. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting. Asian J Transfus Sci 2011;5:157.ChaudharyRAgarwalN.Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting.Asian J Transfus Sci2011;5:157.10.4103/0973-6247.83243315924721897596Search in Google Scholar
Tiwari AK, Aggarwal G, Dara RC, Arora D, Gupta GK, Raina V. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen–negative recipients. Asian J Transfus Sci 2017;11:40–4.TiwariAKAggarwalGDaraRCAroraDGuptaGKRainaV.First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen–negative recipients.Asian J Transfus Sci2017;11:40–4.10.4103/0973-6247.200774534527928316439Search in Google Scholar
Milkins C, Berryma J, Cantwell C, et al. Guidelines for pretransfusion compatibility procedures in blood transfusion laboratories. Transfus Med 2013;23:3–35.MilkinsCBerrymaJCantwellC,Guidelines for pretransfusion compatibility procedures in blood transfusion laboratories.Transfus Med2013;23:3–35.10.1111/j.1365-3148.2012.01199.xSearch in Google Scholar
Aggarwal G, Tiwari AK, Arora D, et al. Advantages of type and screen policy: perspective from a developing country! Asian J Transfus Sci 2018;12:42–5.AggarwalGTiwariAKAroraD,Advantages of type and screen policy: perspective from a developing country!Asian J Transfus Sci2018;12:42–5.10.4103/ajts.AJTS_31_17Search in Google Scholar
Cheng CK, Lee CK, Lin CK. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 2012;52:2220–4.ChengCKLeeCKLinCK.Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.Transfusion2012;52:2220–4.10.1111/j.1537-2995.2012.03570.xSearch in Google Scholar
Moise KJ Jr. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000;92:75–81.MoiseKJJr.Non-anti-D antibodies in red-cell alloimmunization.Eur J Obstet Gynecol Reprod Biol2000;92:75–81.10.1016/S0301-2115(00)00428-0Search in Google Scholar
Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062–71.ChouSTJacksonTVegeSSmith-WhitleyKFriedmanDFWesthoffCM.High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.Blood2013;122:1062–71.10.1182/blood-2013-03-49062323723452Search in Google Scholar
Tiwari AK, Pandey P, Sharma J, Shailja K, Dixit S, Raina V. Incidence of clinically significant antibodies in patients and healthy blood donors: a prospective cross-sectional study from a tertiary healthcare center in India. Transfus Apher Sci 2014;50:230–4.TiwariAKPandeyPSharmaJShailjaKDixitSRainaV.Incidence of clinically significant antibodies in patients and healthy blood donors: a prospective cross-sectional study from a tertiary healthcare center in India.Transfus Apher Sci2014;50:230–4.10.1016/j.transci.2013.08.00824548676Search in Google Scholar
Pahuja S, Gupta SK, Pujani M, Jain M. The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi. Blood Transfus 2011;9:388.PahujaSGuptaSKPujaniMJainM.The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi.Blood Transfus2011;9:388.Search in Google Scholar
LaSalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011;51:1732–9.LaSalle-WilliamsMNussRLeT,Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).Transfusion2011;51:1732–9.10.1111/j.1537-2995.2010.03045.x21332724Search in Google Scholar
Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.VichinskyEPLubanNLWrightE,Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.Transfusion2001;41:1086–92.10.1046/j.1537-2995.2001.41091086.x11552063Search in Google Scholar
Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684–90.CastroOSandlerSGHouston-YuPRanaS.Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.Transfusion2002;42:684–90.10.1046/j.1537-2995.2002.00126.x12147019Search in Google Scholar
Fasano RM, Chou ST. Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev 2016;30:197–201.FasanoRMChouST.Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications.Transfus Med Rev2016;30:197–201.10.1016/j.tmrv.2016.05.01127345938Search in Google Scholar
Gogri H, Kulkarni S, Vasantha K, Jadhav S, Ghosh K, Gorakshakar A. Partial matching of blood group antigens to reduce alloimmunization in Western India. Transfus Apher Sci 2016;54:390–5.GogriHKulkarniSVasanthaKJadhavSGhoshKGorakshakarA.Partial matching of blood group antigens to reduce alloimmunization in Western India.Transfus Apher Sci2016;54:390–5.10.1016/j.transci.2016.02.00227020262Search in Google Scholar
Pal M, Williams B. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia. Pathology 2015;47:151–5.PalMWilliamsB.Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia.Pathology2015;47:151–5.10.1097/PAT.000000000000022525551305Search in Google Scholar
Elhence P, Solanki A, Verma A. Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review. Indian J Hematol Blood Transfus 2014;30:301–8.ElhencePSolankiAVermaA.Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review.Indian J Hematol Blood Transfus2014;30:301–8.10.1007/s12288-013-0311-y424340225435732Search in Google Scholar
Karimi M, Nikrooz P, Kashef S, Jamalian N, Davatolhagh ZR. RBC alloimmunization in blood transfusion-dependent β-thalassemia patients in southern Iran. Int J Lab Hematol 2007;29:321–6.KarimiMNikroozPKashefSJamalianNDavatolhaghZR.RBC alloimmunization in blood transfusion-dependent β-thalassemia patients in southern Iran.Int J Lab Hematol2007;29:321–6.10.1111/j.1365-2257.2006.00856.x17824911Search in Google Scholar
Agrawal A, Mathur A, Dontula S, Jagannathan L. Red blood cell alloimmunization in multi-transfused patients: a bicentric study in India. Glob J Transfus Med 2016;1:12.AgrawalAMathurADontulaSJagannathanL.Red blood cell alloimmunization in multi-transfused patients: a bicentric study in India.Glob J Transfus Med2016;1:12.10.4103/2455-8893.178005Search in Google Scholar
Zaman S, Chaurasia R, Chatterjee K, Thapliyal RM. Prevalence and specificity of RBC alloantibodies in Indian patients attending a tertiary care hospital. Adv Hematol 2014; 2014:749218.ZamanSChaurasiaRChatterjeeKThapliyalRM.Prevalence and specificity of RBC alloantibodies in Indian patients attending a tertiary care hospital.Adv Hematol2014;2014:749218.10.1155/2014/749218421668925386192Search in Google Scholar
Ho HK, Ha SY, Lam CK, et al. Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients. Blood 2001;97:3999–4000.HoHKHaSYLamCK,Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients.Blood2001;97:3999–4000.10.1182/blood.V97.12.3999Search in Google Scholar
Bhagwat SN, Sharma JH, Jose J, Modi CJ. Comparison between conventional and automated techniques for blood grouping and crossmatching: experience from a tertiary care centre. J Lab Physicians 2015;7:96.BhagwatSNSharmaJHJoseJModiCJ.Comparison between conventional and automated techniques for blood grouping and crossmatching: experience from a tertiary care centre.J Lab Physicians2015;7:96.10.4103/0974-2727.163130455963626417159Search in Google Scholar
Nathalang O, Chuansumrit A, Prayoonwiwat W, Siripoonya P, Sriphaisal T. Comparison between the conventional tube technique and the gel technique in direct antiglobulin tests. Vox Sang 1997;72:169–71.NathalangOChuansumritAPrayoonwiwatWSiripoonyaPSriphaisalT.Comparison between the conventional tube technique and the gel technique in direct antiglobulin tests.Vox Sang1997;72:169–71.10.1159/000461985Search in Google Scholar
Das SS, Chaudhary R, Khetan D. A comparison of conventional tube test and gel technique in evaluation of direct antiglobulin test. Hematology 2007;12:175–8.DasSSChaudharyRKhetanD.A comparison of conventional tube test and gel technique in evaluation of direct antiglobulin test.Hematology2007;12:175–8.10.1080/1024533060111186217454201Search in Google Scholar
Novaretti MC, Jens E, Pagliarini T, Bonifacio SL, Dorlhiac–Llacer PE, Chamone DA. Comparison of conventional tube test technique and gel microcolumn assay for direct antiglobulin test: a large study. J Clin Lab Anal 2004;18:255–8.NovarettiMCJensEPagliariniTBonifacioSLDorlhiac–LlacerPEChamoneDA.Comparison of conventional tube test technique and gel microcolumn assay for direct antiglobulin test: a large study.J Clin Lab Anal2004;18:255–8.10.1002/jcla.20033680770915356874Search in Google Scholar
Weisbach V, Kohnhäuser T, Zimmermann R, et al. Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies. Transfus Med 2006;16:276–84.WeisbachVKohnhäuserTZimmermannR,Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies.Transfus Med2006;16:276–84.10.1111/j.1365-3148.2006.00674.x16879156Search in Google Scholar
Bajpai M, Kaur R, Gupta E. Automation in immunohematology. Asian J Transfus Sci 2012;6:140.BajpaiMKaurRGuptaE.Automation in immunohematology.Asian J Transfus Sci2012;6:140.10.4103/0973-6247.98914343975222988378Search in Google Scholar